EUVIMEDOpdag EUVIMED
Crossref

How to better improve the treatment and outcomes of HCV in psychiatric patients: review of a Belgian monocentric psychiatric center

S Chabert, X Saloppe, B Delaunoit, G Dupont, P Yengue

Acta Gastro Enterologica Belgica · 2024

DOI: 10.51821/87.2.12355 ↗

At a glance

Journal article in Acta Gastro Enterologica Belgica, 2024. Written by S Chabert and 4 co-authors. Institution: Hepatogastroenterology department, Chwapi, Tournai, Belgium. Major MEDLINE topics: Antiviral Agents, Mental Disorders. 25 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Hepatitis C (HCV) is one of the major worldwide infections with 58 million infected persons in the world. HCV can lead to chronic liver disease, cirrhosis, and cancer. These past few years, clinical progress allowed a curative rate of 95% of the patients. There are still populations in which, treating the disease is more difficult, especially psychiatric patients, when substance abuse, psychiatric disorders are important risks factors for getting HCV. With the WHO organization establishing goals for clinical management and treatment of HCV, it is important to target where the difficulties lie in getting a better treatment program for those populations.

Aim

Try to highlight the challenges of treating a certain group of patients compare to the general population.

Method

This is a cross sectional monocentric study. 79 patients from a mental facility were included between 2012 and 2022. Inclusion criteria were: >18 years old, an active viral HCV infection.

Results

34.7% of patients with a positive PCR were treated with a significant difference between the closed psychiatric unit and the open one (66.5 vs 22.6%, p

Subjects

MeSH terms (MEDLINE)

Antiviral AgentsMental DisordersHumansMaleCross-Sectional StudiesFemaleMiddle AgedAdultBelgiumHepatitis C, ChronicTreatment OutcomeHepatitis CHospitals, PsychiatricSustained Virologic Response

Author keywords

Sustained Viral Responsehepatitis Cpsychiatric centerpsychiatric disease

Substances

Antiviral Agents

Authors and institutions

  • Hepatogastroenterology department, Chwapi, Tournai, Belgium.
  • Research Center in Social Defense, Tournai, Belgium.
  • Psychiatric center, Les Marronniers,Tournai, Belgium.

Cite

APA

Chabert, S., Saloppe, X., Delaunoit, B., Dupont, G., & Yengue, P. (2024). How to better improve the treatment and outcomes of HCV in psychiatric patients: review of a Belgian monocentric psychiatric center. Acta Gastro Enterologica Belgica. https://doi.org/10.51821/87.2.12355

Vancouver

Chabert S, Saloppe X, Delaunoit B, Dupont G, Yengue P. How to better improve the treatment and outcomes of HCV in psychiatric patients: review of a Belgian monocentric psychiatric center. Acta Gastro Enterologica Belgica. 2024. doi:10.51821/87.2.12355

BibTeX
@article{Chabert2024,
  author = {Chabert, S and Saloppe, X and Delaunoit, B and Dupont, G and Yengue, P},
  title = {How to better improve the treatment and outcomes of HCV in psychiatric patients: review of a Belgian monocentric psychiatric center},
  journal = {Acta Gastro Enterologica Belgica},
  year = {2024},
  doi = {10.51821/87.2.12355}
}
Start for free →